VS-5584 mediates potent anti-myeloma activity via the upregulation of a class II tumor suppressor gene, RARRES3 and the activation of Bim
Mustafa, Nurulhuda, Ting Lee, Jeannie Xue, Adina Nee, Huey Fang, Bi, Chonglei, Chung, Tae-Hoon, Hart, Stefan, Chng, Wee Joo
Published in Oncotarget (24.11.2017)
Published in Oncotarget (24.11.2017)
Get full text
Journal Article
Discovery of a potent histone deacetylase (HDAC) 3/6 selective dual inhibitor
Soumyanarayanan, Uttara, Ramanujulu, Pondy Murugappan, Mustafa, Nurulhuda, Haider, Shozeb, Fang Nee, Adina Huey, Tong, Jie Xin, Tan, Kevin S.W., Chng, Wee Joo, Dymock, Brian W.
Published in European journal of medicinal chemistry (15.12.2019)
Published in European journal of medicinal chemistry (15.12.2019)
Get full text
Journal Article
Determinants of response to daratumumab in Epstein-Barr virus-positive natural killer and T-cell lymphoma
Mustafa, Nurulhuda, Nee, Adina Huey Fang, Chooi, Jing Yuan, Toh, Sabrina Hui Min, Chung, Tae-Hoon, Selvarajan, Viknesvaran, Fan, Shuangyi, Ng, Siok Bian, Poon, Michelle, Chan, Esther, Lee, Joanne, Chee, Yen Lin, Jeyasekharan, Anand D, Zhou, Longen, Yang, Jennifer, Chng, Wee Joo
Published in Journal for immunotherapy of cancer (01.07.2021)
Published in Journal for immunotherapy of cancer (01.07.2021)
Get full text
Journal Article
CD55 and CD59 Can Limit the Anti-Tumor Efficacy of Daratumumab in Natural Killer/T-Cell Lymphoma
Mustafa, Nurulhuda, Nee, Adina Huey Fang, Chooi, Jing Yuan, Toh, Sabrina Hui Min, Hee, Yan Ting, Selvarajan, Viknesvaran, Zhou, Longen, Yang, Jennifer, Chng, Wee Joo
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Daratumumab Efficiently Targets NK/T Cell Lymphoma with High CD38 Expression
Mustafa, Nurulhuda, Nee, Huey Fang Adina, Lee, Xue Ting Jeannie, Jin, Wei, Yu, Yiling, Chen, Yingnan, Yang, Jennifer, Chng, Wee Joo
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article